Learn More
Apexbio Technology LLC FR054 35954-65-5 10mg

Supplier: Apexbio Technology LLC A896310
FR054 is a small-molecule inhibitor targeting phosphoglucomutase 3 (PGM3) It is designed to inhibit PGM3 thereby disrupting the hexosamine biosynthesis pathway and cellular glycosylation processes FR054 exerts its biological activity primarily through inhibition of PGM3 leading to altered glycosylation metabolism and impaired cellular viability Based on these pharmacological properties FR054 holds research potential in cancer metabolism glycosylation and the mechanistic study of metabolic dependencies in oncology
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.